---
figid: PMC7953226__10.1177_1758835920949418-fig1
figtitle: EGFR pathway and targets for combination strategies in HNSCC.EGFR, epidermal
  growth factor receptor; HNSCC, head and neck cancer squamous cell carcinoma
organisms:
- Human papillomavirus
- Human papillomavirus types
- Homo sapiens
- Nicotiana tabacum
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC7953226
filename: 10.1177_1758835920949418-fig1.jpg
figlink: pmc/articles/PMC7953226/figure/fig1-1758835920949418/
number: F1
caption: EGFR pathway and targets for combination strategies in HNSCC.EGFR, epidermal
  growth factor receptor; HNSCC, head and neck cancer squamous cell carcinoma.
papertitle: 'Head and neck cancer: the role of anti-EGFR agents in the era of immunotherapy.'
reftext: Morena Fasano, et al. Ther Adv Med Oncol. 2021;13:1758835920949418.
year: '2021'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9495807
figid_alias: PMC7953226__F1
figtype: Figure
redirect_from: /figures/PMC7953226__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7953226__10.1177_1758835920949418-fig1.html
  '@type': Dataset
  description: EGFR pathway and targets for combination strategies in HNSCC.EGFR,
    epidermal growth factor receptor; HNSCC, head and neck cancer squamous cell carcinoma.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EGFR
  - ERBB2
  - KDR
  - CD274
  - KRAS
  - HRAS
  - NRAS
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - PDK1
  - PDPK1
  - AKT1
  - AKT2
  - AKT3
  - EPHB2
  - MAPK1
  - MAPK3
  - Egfr
  - ras
  - Ras64B
  - Ras85D
  - Pi3K92E
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Raf
  - Pdk1
  - Akt
  - Erk7
  - rl
  - Afatinib
  - Lapatinib Afatinib
  - Vandetanib
  - Gefitinib
  - Erlotinib
  - Lapatinib
---
